Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2004New England Journal of Medicine

Treatment of von Willebrand's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPier Mannuccio Mannucci

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pier Mannuccio Mannucci (2004) studied this question.

synapsesocial.com/papers/6a6f9853fe4101aa97dfd757https://doi.org/10.1056/nejmra040403
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A novel candidate mutation (Arg611→ His) in type I‘platelet discordant’von Willebrand's disease with desmopressin‐induced thrombocytopenia1995 · 29 citations
  2. 2Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P<sup>®</sup>): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy2003 · 73 citations
  3. 3Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease2000 · 177 citations
  4. 4Clinical and laboratory evaluation of the treatment of von Willebrand's disease patients with heat‐treated factor VIII concentrate (BPL 8Y)1990 · 41 citations